Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-Text (PDF)

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

Research Article


Aqueous Bark Extract of Cinnamomum Zeylanicum: A Potential Therapeutic Agent for Streptozotocin-Induced Type 1 Diabetes Mellitus (T1DM) Rats 

Syed A Hassan1*, Ritu Barthwal2, Maya S Nair2 and Syed S Haque

1Department of Biotechnology, Institute of Life Sciences, University of Hyderabad Campus, Hyderabad, 2Molecular Biophysics Laboratory, Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee, 3Department of Clinical Biochemistry, Indira Gandhi Institute of Medical Sciences, Patna, India.

*For correspondence: Email: asif_srmcbt@yahoo.com  Tel: +91-9031737458

Received:  31 August 2011                                          Revised accepted: 23 April 2012

Tropical Journal of Pharmaceutical Research, June 2012; 11(3): 429-435

http://dx.doi.org/10.4314/tjpr.v11i3.12  

Abstract

 

Purpose: To investigate the anti-diabetic, hepatoprotective and lipid homeostatic activity of Cinnamomum zeylanicum aqueous bark extract on streptozotocin (STZ)-induced type-I diabetic rats.

Methods: The animals were divided into three groups (n = 6). of normal rats; streptozotocin-induced diabetic rats; and diabetic rats treated with 200 mg/kg of the aqueous bark extract, respectively. Treatment was via the oral route for 15 days. Various biochemical parameters, including lipid profile and glycogen biosynthesis were analysed. Similarly, differential regulation and expression of glucose homeostatic enzymes were evaluated in order to validate the anti-diabetic activity of the extract.

Results: Total cholesterol (TC), triglyceride (TG), LDL-cholesterol (LDL) and VLDL-cholesterol (VLDL) levels decreased significantly (p < 0.05) in the diabetic animals by 12.5, 23.86, 14.96 and 20 %, respectively, compared to their initial values. The extract increased HDL-cholesterol (HDL) and tissue glycogen levels by 25.0 and 172.3 %, respectively, in diabetic rats. Similarly, differential regulation and expression of glucose homeostatic enzymes, namely, glucokinase (GK), glucose-6-phosphatase (G6Pase), phosphoenol pyruvate carboxykinase (PEPCK), glucose-6-phosphate dehydrogenase (G-6-PDH) and Insulin II (Ins II), showed significant improvement upon extract treatment in STZ-induced diabetic rats.

Conclusion: These results demonstrate the anti-diabetic, and hypolipidemic activities of Cinnamomum zeylanicum aqueous bark extract in diabetic rats.

 

Keywords: Streptozotocin, Type 1 diabetes mellitus, Cinnamomum zeylanicum, Glucose homeostasis, Hypoglycemia, Lipid homeostasis.

Copyright@2002-2010. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net